Case Report: Unicentric Castleman disease mimicking metastatic lymphadenopathy in a patient with a history of triple-negative breast cancer and angiomatoid fibrous histiocytoma
- 1epartment of Medical Ultrasound, Shandong Medicine and Health Key Laboratory of Abdominal Medical Imaging, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China
Abstract
BackgroundCastleman disease (CD) is a rare and highly heterogeneous group of lymphoproliferative disorders. Its imaging manifestations may overlap with those of metastatic lymphadenopathy associated with malignant tumors, making the differential diagnosis of newly detected lymph node abnormalities particularly challenging in patients with a history of malignancy. Angiomatoid fibrous histiocytoma (AFH) is a rare intermediate soft tissue tumor, and the occurrence of CD in patients with a prior history of AFH has rarely been described.Case summaryWe report a 38-year-old Asian woman with prior left-sided triple-negative breast cancer treated with radical surgery and adjuvant therapy. Seven years later, a left post-occipital soft tissue mass was excised and diagnosed as AFH with an EWSR1 gene rearrangement. One year later, she noticed newly enlarged left cervical lymph nodes, raising concern for tumor recurrence or metastasis. Imaging revealed multiple lesions within the ipsilateral head and neck lymphatic drainage region. Excisional biopsy of a left level II cervical lymph node showed no evidence of malignancy on frozen section, while definitive histopathology established plasma cell-type Castleman disease. Subsequent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) showed no definite abnormal lymphadenopathy in the thorax, abdomen, or pelvis, and biopsy of a left post-occipital lesion distinct from the excised AFH mass showed concordant CD-related changes. The disease was classified as unicentric Castleman disease (UCD) based on regional lesion distribution, laboratory and pathological findings, and the absence of overt systemic inflammatory manifestations or multiorgan involvement. Given the potential morbidity of complete excision, close surveillance was chosen. Six-month follow-up showed stable clinical and imaging findings.ConclusionThis case highlights the diagnostic challenges associated with the rare sequential occurrence of triple-negative breast cancer, angiomatoid fibrous histiocytoma, and Castleman disease. In patients with complex oncological histories, newly detected lymphadenopathy should not be presumed to indicate tumor recurrence or metastasis, as tumor-associated lymphoid changes and Castleman disease may present with overlapping clinical and imaging features. Accurate diagnosis and classification require integration of histopathological findings, lesion distribution, laboratory results, and clinical context. Furthermore, management should be individualized according to disease distribution, surgical feasibility, potential morbidity, and the patient's overall clinical condition.
Related
- Angiomatoid Fibrous Histiocytoma
- Metastatic Lymphadenopathy As the Initial Presentation of Gastric Carcinoma: A Case Report
- Recurrent aneurysmal fibrous histiocytoma of the breast with malignant features: a rare case report
- Primary bronchial fibrous histiocytoma mimicking refractory asthma in a child: A fatal case of misdiagnosis and airway obstruction.
- A Chronic Painful Palmar Lesion with Regional Lymphadenopathy
BibTeX
@article{he2026case,
title = {{Case Report: Unicentric Castleman disease mimicking metastatic lymphadenopathy in a patient with a history of triple-negative breast cancer and angiomatoid fibrous histiocytoma}},
author = {Min He and Jing Fu and Haiyan Wang},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1985669},
url = {https://doi.org/10.3389/fonc.2026.1985669},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Case Report: Unicentric Castleman disease mimicking metastatic lymphadenopathy in a patient with a history of triple-negative breast cancer and angiomatoid fibrous histiocytoma
AU - Min He
AU - Jing Fu
AU - Haiyan Wang
PY - 2026
DA - 2026/10/23
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1985669
UR - https://doi.org/10.3389/fonc.2026.1985669
AB - BackgroundCastleman disease (CD) is a rare and highly heterogeneous group of lymphoproliferative disorders. Its imaging manifestations may overlap with those of metastatic lymphadenopathy associated with malignant tumors, making the differential diagnosis of newly detected lymph node abnormalities particularly challenging in patients with a history of malignancy. Angiomatoid fibrous histiocytoma (AFH) is a rare intermediate soft tissue tumor, and the occurrence of CD in patients with a prior history of AFH has rarely been described.Case summaryWe report a 38-year-old Asian woman with prior left-sided triple-negative breast cancer treated with radical surgery and adjuvant therapy. Seven years later, a left post-occipital soft tissue mass was excised and diagnosed as AFH with an EWSR1 gene rearrangement. One year later, she noticed newly enlarged left cervical lymph nodes, raising concern for tumor recurrence or metastasis. Imaging revealed multiple lesions within the ipsilateral head and neck lymphatic drainage region. Excisional biopsy of a left level II cervical lymph node showed no evidence of malignancy on frozen section, while definitive histopathology established plasma cell-type Castleman disease. Subsequent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) showed no definite abnormal lymphadenopathy in the thorax, abdomen, or pelvis, and biopsy of a left post-occipital lesion distinct from the excised AFH mass showed concordant CD-related changes. The disease was classified as unicentric Castleman disease (UCD) based on regional lesion distribution, laboratory and pathological findings, and the absence of overt systemic inflammatory manifestations or multiorgan involvement. Given the potential morbidity of complete excision, close surveillance was chosen. Six-month follow-up showed stable clinical and imaging findings.ConclusionThis case highlights the diagnostic challenges associated with the rare sequential occurrence of triple-negative breast cancer, angiomatoid fibrous histiocytoma, and Castleman disease. In patients with complex oncological histories, newly detected lymphadenopathy should not be presumed to indicate tumor recurrence or metastasis, as tumor-associated lymphoid changes and Castleman disease may present with overlapping clinical and imaging features. Accurate diagnosis and classification require integration of histopathological findings, lesion distribution, laboratory results, and clinical context. Furthermore, management should be individualized according to disease distribution, surgical feasibility, potential morbidity, and the patient's overall clinical condition.
SN - 2234-943X
ER -